News
-
-
PRESS RELEASE
NioCorp to Participate in the J.P. Morgan Export & Agency Finance Forum on October 8, 2025
NioCorp executives to participate in Critical Minerals Forum Summit in Washington, D.C. and J.P. Morgan Export & Agency Finance Forum in Paris, France, highlighting Elk Creek Project's potential to help reshore U.S. production of critical minerals -
PRESS RELEASE
Murchison Minerals Intersects High-Grade Copper-Zinc Mineralization in Backpack Drillholes at BMK Deposit - Diamond Drill Program To Commence Early October
Murchison Minerals Ltd. starts 2025 Exploration Program at BMK Project in Saskatchewan. Identifying high-grade copper-zinc mineralization, aiming to expand BMK Deposit -
-
PRESS RELEASE
Eightco Holdings Inc. ($ORBS) Expands Investor Access with Options Trading
Eightco Holdings Inc. (NASDAQ: ORBS) expands investor access with options trading, reaching 17 million verified humans and introducing 'Power of 8' initiative targeting 800M Worldcoin (WLD) and 8B verified humans. Chairman Dan Ives leads the company's growth and accessibility efforts -
-
-
PRESS RELEASE
Jochen Lischer reappointed as member of the Executive Board and CFO of PWO AG for another 5 years
Jochen Lischer reappointed as member of the Executive Board and CFO of PWO AG for another 5 years. The decision reflects the Supervisory Board's confidence in his leadership and professional competence -
PRESS RELEASE
The Platform Group Targets EUR 1 Billion in Revenue for 2026, Completes Three Acquisitions in the Pharmaceutical Sector
The Platform Group AG aims for EUR 1 billion revenue in 2026 after completing three acquisitions in the pharmaceutical sector. Raised guidance includes EUR 70-80 million EBITDA in 2026 -
PRESS RELEASE
EQS-Adhoc: The Platform Group AG raises its forecast for 2026 to EUR 1 billion in sales and EUR 70–80 million in EBITDA – three acquisitions in the pharmaceutical sector and expansion in the Optics & Hearing s
The Platform Group AG raises its 2026 forecast to EUR 1 billion in sales and EUR 70–80 million in EBITDA due to acquisitions in pharmaceutical sector and Optics & Hearing expansion
